Latest Close
₹3,976.70
+4.83%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹3,273.98
200 DMA
₹2,693.54
1 year gain / loss
+₹2,273.20(+133.44%)
₹1,703.50 → ₹3,976.70· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-11-01 · Financial period Sep 2026 · Consolidated figures where available
Acutaas Chemicals Limited, formerly Ami Organics Limited, is a manufacturer of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.
Market Cap
₹32,770.14 Cr
P/E
74.70×
Sector -38.72× · above
P/B
17.64×
Sector 4.11× · above
EV / EBITDA
50.30×
Sector 22.21× · above
ROE
23.64%
Sector 0.31%
ROCE
32.25%
Sector 6.48%
ROA
19.75%
Sector -17.12%
Cash Flow / Profit
0.82×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Sep 2026 | 442.02 +33.4% | 167.36 | 123.14 +64.2% |
| Jun 2026 | 331.47 -25.3% | 103.91 | 74.99 -44.1% |
| Mar 2026 | 443.86 +11.6% | 183.8 | 134.28 +26.4% |
| Dec 2025 | 397.88 | 144.67 | 106.22 |
Dividend
17 Sep 2026 · ₹2.5